Promotion of IL8, IL10, TNFα and TNFβ production by EBV infection
Authors:
- Sigrid C. KleinSKSigrid C. Klein
- Dieter KubeDKDieter Kube
- Harry AbtsHAHarry Abts
- Volker DiehlVDVolker Diehl
- Hans TeschHTHans Tesch
- 1 August 1996
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 20 (8) , 633-636
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Isolation of the Human Interleukin 10 Promoter. Characterization of the Promoter Activity in Burkitt's Lymphoma Cell LinesCytokine, 1995
- Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell linesEuropean Journal of Immunology, 1994
- QUANTITATIVE PCR ANALYSIS OF CYTOKINE TRANSCRIPTION PATTERNS IN PERIPHERAL MONONUCLEAR CELLS AFTER ANTI-CD3 REJECTION THERAPY USING TWO NOVEL MULTISPECIFIC COMPETITOR FRAGMENTS1Transplantation, 1994
- The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma linesInternational Journal of Cancer, 1994
- Cytokines in malignant lymphomas: Review and prospective evaluationHuman Pathology, 1993
- The Epstein‐Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis‐element of the terminal protein 1 gene promoter.The EMBO Journal, 1993
- Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extractionAnalytical Biochemistry, 1987
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell, 1985
- Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphomaNature, 1982
- Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAsJournal of Virology, 1980